Traditional Chinese medicine for antibiotic-resistant pneumonia
Part of Infections, Lungs & breathing clinical trials.
This trial is testing whether a special traditional Chinese medicine formula can help treat pneumonia caused by bacteria that don't respond to many standard antibiotics. If you are hospitalized with this type of pneumonia, the study aims to find a new treatment option to help you fight the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and in the hospital with pneumonia.
- A lab test has found that the bacteria causing your pneumonia is multidrug-resistant (doesn't respond to many antibiotics).
- Your doctors believe the resistant bacteria is the main cause of your current pneumonia, not just a harmless bug on your skin or equipment.
- You are willing to take part and can give written consent (or a family member or legal guardian can give it for you).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of traditional Chinese and Western medicine for adults with severe pneumonia caused by bacteria that are resistant to multiple antibiotics. It aims to see if this combined approach can improve treatment outcomes.
This study looks at whether traditional Chinese medicine can help treat severe pneumonia. It follows patients over time to see how well the treatment works.
This early-stage trial tests a combination of a traditional Chinese herbal formula and bacteriophages (viruses that kill bacteria) to treat severe pneumonia caused by drug-resistant bacteria. The treatment is inhaled directly into the lungs and may help when standard antibiotics don't work.
This trial tests whether adding a Chinese herbal formula (Yiqi Huoxue Jiedu) and inhaled bacteriophages (viruses that kill bacteria) to standard care can help treat severe pneumonia caused by drug-resistant bacteria like Klebsiella, Acinetobacter, or Pseudomonas. It is for adults aged 18 to 85 who are not pregnant or immunocompromised and can undergo a bronchoscopy to collect samples.
This study tests whether adding NRICM102, a traditional Chinese medicine, to standard antibiotic treatment helps hospitalized patients with community-acquired pneumonia (a lung infection acquired outside a hospital) recover better. You would receive the herbal medicine by mouth along with your regular antibiotics.
This trial studies whether Chinese herbal medicine can help people hospitalized with pneumonia. It compares the herbal treatment to usual care to see if it improves recovery.
Hear when a new Multi Drug Resistant Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.